Global Internal Neuromodulation Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 152530
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 120
  • list Medical Devices

Neuromodulation is used to regulate functions of nervous system, such as therapeutic alteration, inhibition, stimulation, modification, and others. There are two types of neuromodulation external neuromodulation and internal neuromodulation. Internal neuromodulation block or repair neuron signals of pain from reaching the brain using electrical impulses. These devices reduce highest levels of pain for various chronic or refractory diseases. Its clinical significance in pain reduction and therapeutics has lead a wide acceptance in the North American region.

Scope of the Report:

The driving factors of the internal neuromodulation market are rising prevalence of neurological disorders, increase in the aging population, strong product pipeline, expanded target applications and new indications, and investments and funds. Moreover, technological advancements present opportunities for growth of the market.

The worldwide market for Internal Neuromodulation is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the Internal Neuromodulation in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Medtronic PLC

St. Jude Medical

Boston Scientific Corp.

Cerbomed GMBH

Cyberonics Inc.

Biocontrol Medical

Depuy Synthes Companies

Enteromedics Inc.

Synapse Biomedical INC.

Uroplasty Inc

Greatbatch

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Spinal Cord Stimulator

Deep Brain Stimulator

Sacral Nerve Stimulator

Vagus Nerve Stimulator

Gastric Neuro Stimulator

Market Segment by Applications, can be divided into

Parkinsons Disease

Chronic Pain

Others

There are 15 Chapters to deeply display the global Internal Neuromodulation market.

Chapter 1, to describe Internal Neuromodulation Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Internal Neuromodulation, with sales, revenue, and price of Internal Neuromodulation, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Internal Neuromodulation, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Internal Neuromodulation market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Internal Neuromodulation sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Internal Neuromodulation Introduction

1.2 Market Analysis by Type

1.2.1 Spinal Cord Stimulator

1.2.2 Deep Brain Stimulator

1.2.3 Sacral Nerve Stimulator

1.2.4 Vagus Nerve Stimulator

1.2.5 Gastric Neuro Stimulator

1.3 Market Analysis by Applications

1.3.1 Parkinsons Disease

1.3.2 Chronic Pain

1.3.3 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Medtronic PLC

2.1.1 Business Overview

2.1.2 Internal Neuromodulation Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Medtronic PLC Internal Neuromodulation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 St. Jude Medical

2.2.1 Business Overview

2.2.2 Internal Neuromodulation Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 St. Jude Medical Internal Neuromodulation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Boston Scientific Corp.

2.3.1 Business Overview

2.3.2 Internal Neuromodulation Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Boston Scientific Corp. Internal Neuromodulation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Cerbomed GMBH

2.4.1 Business Overview

2.4.2 Internal Neuromodulation Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Cerbomed GMBH Internal Neuromodulation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Cyberonics Inc.

2.5.1 Business Overview

2.5.2 Internal Neuromodulation Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Cyberonics Inc. Internal Neuromodulation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Biocontrol Medical

2.6.1 Business Overview

2.6.2 Internal Neuromodulation Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Biocontrol Medical Internal Neuromodulation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Depuy Synthes Companies

2.7.1 Business Overview

2.7.2 Internal Neuromodulation Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Depuy Synthes Companies Internal Neuromodulation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Enteromedics Inc.

2.8.1 Business Overview

2.8.2 Internal Neuromodulation Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Enteromedics Inc. Internal Neuromodulation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Synapse Biomedical INC.

2.9.1 Business Overview

2.9.2 Internal Neuromodulation Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Synapse Biomedical INC. Internal Neuromodulation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Uroplasty Inc

2.10.1 Business Overview

2.10.2 Internal Neuromodulation Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Uroplasty Inc Internal Neuromodulation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.11 Greatbatch

2.11.1 Business Overview

2.11.2 Internal Neuromodulation Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Greatbatch Internal Neuromodulation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Internal Neuromodulation Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Internal Neuromodulation Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Internal Neuromodulation Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Internal Neuromodulation Manufacturer Market Share in 2017

3.3.2 Top 6 Internal Neuromodulation Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Internal Neuromodulation Market Analysis by Regions

4.1 Global Internal Neuromodulation Sales, Revenue and Market Share by Regions

4.1.1 Global Internal Neuromodulation Sales and Market Share by Regions (2013-2018)

4.1.2 Global Internal Neuromodulation Revenue and Market Share by Regions (2013-2018)

4.2 North America Internal Neuromodulation Sales and Growth Rate (2013-2018)

4.3 Europe Internal Neuromodulation Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Internal Neuromodulation Sales and Growth Rate (2013-2018)

4.5 South America Internal Neuromodulation Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Internal Neuromodulation Sales and Growth Rate (2013-2018)

5 North America Internal Neuromodulation by Countries

5.1 North America Internal Neuromodulation Sales, Revenue and Market Share by Countries

5.1.1 North America Internal Neuromodulation Sales and Market Share by Countries (2013-2018)

5.1.2 North America Internal Neuromodulation Revenue and Market Share by Countries (2013-2018)

5.2 United States Internal Neuromodulation Sales and Growth Rate (2013-2018)

5.3 Canada Internal Neuromodulation Sales and Growth Rate (2013-2018)

5.4 Mexico Internal Neuromodulation Sales and Growth Rate (2013-2018)

6 Europe Internal Neuromodulation by Countries

6.1 Europe Internal Neuromodulation Sales, Revenue and Market Share by Countries

6.1.1 Europe Internal Neuromodulation Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Internal Neuromodulation Revenue and Market Share by Countries (2013-2018)

6.2 Germany Internal Neuromodulation Sales and Growth Rate (2013-2018)

6.3 UK Internal Neuromodulation Sales and Growth Rate (2013-2018)

6.4 France Internal Neuromodulation Sales and Growth Rate (2013-2018)

6.5 Russia Internal Neuromodulation Sales and Growth Rate (2013-2018)

6.6 Italy Internal Neuromodulation Sales and Growth Rate (2013-2018)

7 Asia-Pacific Internal Neuromodulation by Countries

7.1 Asia-Pacific Internal Neuromodulation Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Internal Neuromodulation Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Internal Neuromodulation Revenue and Market Share by Countries (2013-2018)

7.2 China Internal Neuromodulation Sales and Growth Rate (2013-2018)

7.3 Japan Internal Neuromodulation Sales and Growth Rate (2013-2018)

7.4 Korea Internal Neuromodulation Sales and Growth Rate (2013-2018)

7.5 India Internal Neuromodulation Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Internal Neuromodulation Sales and Growth Rate (2013-2018)

8 South America Internal Neuromodulation by Countries

8.1 South America Internal Neuromodulation Sales, Revenue and Market Share by Countries

8.1.1 South America Internal Neuromodulation Sales and Market Share by Countries (2013-2018)

8.1.2 South America Internal Neuromodulation Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Internal Neuromodulation Sales and Growth Rate (2013-2018)

8.3 Argentina Internal Neuromodulation Sales and Growth Rate (2013-2018)

8.4 Colombia Internal Neuromodulation Sales and Growth Rate (2013-2018)

9 Middle East and Africa Internal Neuromodulation by Countries

9.1 Middle East and Africa Internal Neuromodulation Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Internal Neuromodulation Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Internal Neuromodulation Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Internal Neuromodulation Sales and Growth Rate (2013-2018)

9.3 UAE Internal Neuromodulation Sales and Growth Rate (2013-2018)

9.4 Egypt Internal Neuromodulation Sales and Growth Rate (2013-2018)

9.5 Nigeria Internal Neuromodulation Sales and Growth Rate (2013-2018)

9.6 South Africa Internal Neuromodulation Sales and Growth Rate (2013-2018)

10 Global Internal Neuromodulation Market Segment by Type

10.1 Global Internal Neuromodulation Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Internal Neuromodulation Sales and Market Share by Type (2013-2018)

10.1.2 Global Internal Neuromodulation Revenue and Market Share by Type (2013-2018)

10.2 Spinal Cord Stimulator Sales Growth and Price

10.2.1 Global Spinal Cord Stimulator Sales Growth (2013-2018)

10.2.2 Global Spinal Cord Stimulator Price (2013-2018)

10.3 Deep Brain Stimulator Sales Growth and Price

10.3.1 Global Deep Brain Stimulator Sales Growth (2013-2018)

10.3.2 Global Deep Brain Stimulator Price (2013-2018)

10.4 Sacral Nerve Stimulator Sales Growth and Price

10.4.1 Global Sacral Nerve Stimulator Sales Growth (2013-2018)

10.4.2 Global Sacral Nerve Stimulator Price (2013-2018)

10.5 Vagus Nerve Stimulator Sales Growth and Price

10.5.1 Global Vagus Nerve Stimulator Sales Growth (2013-2018)

10.5.2 Global Vagus Nerve Stimulator Price (2013-2018)

10.6 Gastric Neuro Stimulator Sales Growth and Price

10.6.1 Global Gastric Neuro Stimulator Sales Growth (2013-2018)

10.6.2 Global Gastric Neuro Stimulator Price (2013-2018)

11 Global Internal Neuromodulation Market Segment by Application

11.1 Global Internal Neuromodulation Sales Market Share by Application (2013-2018)

11.2 Parkinsons Disease Sales Growth (2013-2018)

11.3 Chronic Pain Sales Growth (2013-2018)

11.4 Others Sales Growth (2013-2018)

12 Internal Neuromodulation Market Forecast (2018-2023)

12.1 Global Internal Neuromodulation Sales, Revenue and Growth Rate (2018-2023)

12.2 Internal Neuromodulation Market Forecast by Regions (2018-2023)

12.2.1 North America Internal Neuromodulation Market Forecast (2018-2023)

12.2.2 Europe Internal Neuromodulation Market Forecast (2018-2023)

12.2.3 Asia-Pacific Internal Neuromodulation Market Forecast (2018-2023)

12.2.4 South America Internal Neuromodulation Market Forecast (2018-2023)

12.2.5 Middle East and Africa Internal Neuromodulation Market Forecast (2018-2023)

12.3 Internal Neuromodulation Market Forecast by Type (2018-2023)

12.3.1 Global Internal Neuromodulation Sales Forecast by Type (2018-2023)

12.3.2 Global Internal Neuromodulation Market Share Forecast by Type (2018-2023)

12.4 Internal Neuromodulation Market Forecast by Application (2018-2023)

12.4.1 Global Internal Neuromodulation Sales Forecast by Application (2018-2023)

12.4.2 Global Internal Neuromodulation Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Internal Neuromodulation Picture

Table Product Specifications of Internal Neuromodulation

Figure Global Sales Market Share of Internal Neuromodulation by Types in 20

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery